Biogen (BIIB) Invested Capital (2009 - 2026)
Biogen's Invested Capital came in at $26.21 billion for Q3 2026, up 7.0% from $24.49 billion a year earlier and up 0.3% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Invested Capital (2009 - 2026) Analysis & Trends
For FY2025, Biogen's Invested Capital was $24.54 billion, up 6.7% from FY2024.
- Invested Capital has increased in each of the last five years, with a five-year compound annual growth rate of 6.3% (FY2020 to FY2025).
- Going back by year, Invested Capital was $23.01 billion in FY2024 (+5.9%), $21.74 billion in FY2023 (+10.5%), $19.67 billion in FY2022 (+2.3%) and $19.23 billion in FY2021 (+6.2%).
- The Q3 2026 figure represents the highest quarterly Invested Capital in data going back to Q2 2009.
- Year-over-year, Invested Capital increased in seven of the last eight quarters, with growth averaging 6.3%.
- The fastest year-over-year change in Invested Capital over five years came in Q3 2024 (growth of 14.7%), and the weakest in Q3 2022 (a decline of 0.6%).
- Business Quant data shows BIIB's Invested Capital at $26.14 billion (Q2 2026), $24.94 billion (Q1 2026) and $24.54 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 26.21 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.21 Bn |
| Jun 30, 2026 | 26.14 Bn |
| Mar 31, 2026 | 24.94 Bn |
| Dec 31, 2025 | 24.54 Bn |
| Sep 30, 2025 | 24.49 Bn |
| Jun 30, 2025 | 23.92 Bn |
| Mar 31, 2025 | 25.03 Bn |
| Dec 31, 2024 | 23.01 Bn |
| Sep 30, 2024 | 24.40 Bn |
| Jun 30, 2024 | 22.18 Bn |
| Mar 31, 2024 | 22.00 Bn |
| Dec 31, 2023 | 21.74 Bn |
| Sep 30, 2023 | 21.27 Bn |
| Jun 30, 2023 | 20.75 Bn |
| Mar 31, 2023 | 20.07 Bn |
| Dec 31, 2022 | 19.67 Bn |
| Sep 30, 2022 | 19.05 Bn |
| Jun 30, 2022 | 20.14 Bn |
| Mar 31, 2022 | 19.50 Bn |
| Dec 31, 2021 | 19.23 Bn |
API Access
Biogen Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();